Board Change • May 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Apr 09
Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million. Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.
Security Name: Common Stock
Security Type: Common Stock
Transaction Features: At the Market Offering Tillkännagivande • Mar 30
Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026 Aehr Test Systems, Inc. announced that they will report Q3, 2026 results After-Market on Apr 07, 2026 Tillkännagivande • Jan 09
Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026 Aehr Test Systems, Inc. reinstated earnings guidance for the second half of fiscal 2026. For the period, which began November 29, 2025 and ends this May 29, 2026, Aehr expects revenue between $25 million and $30 million. Tillkännagivande • Dec 30
Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026 Aehr Test Systems, Inc. announced that they will report Q2, 2026 results After-Market on Jan 08, 2026 Tillkännagivande • Sep 29
Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025 Aehr Test Systems, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on Oct 06, 2025 Tillkännagivande • Sep 11
Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025 Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025. Location: 400kato terrace, california 94539, fremont United States Tillkännagivande • Jun 30
Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025 Aehr Test Systems, Inc. announced that they will report Q4, 2025 results After-Market on Jul 08, 2025 Tillkännagivande • Mar 28
Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025 Aehr Test Systems, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2025 Tillkännagivande • Jan 14
Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025 For the fiscal year ending May 30, 2025, Aehr Test Systems, Inc. reiterated its previously provided guidance for total revenue of at least $70 million. Tillkännagivande • Jan 01
Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025 Aehr Test Systems, Inc. announced that they will report Q2, 2025 results at 4:00 PM, US Eastern Standard Time on Jan 13, 2025 Board Change • Dec 30
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Dec 06
Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, Inc Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (2) the foregoing issue was likely to have a material negative impact on the Company's revenue growth; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AEHR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Aehr you have until February 3, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes. Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €12.74, the stock trades at a trailing P/E ratio of 14.3x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total loss to shareholders of 44% over the past three years. Tillkännagivande • Oct 16
Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million. Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.
Security Name: Common Stock
Security Type: Common Stock
Transaction Features: At the Market Offering Reported Earnings • Oct 11
First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024) First quarter 2025 results: EPS: US$0.023 (down from US$0.16 in 1Q 2024). Revenue: US$13.1m (down 36% from 1Q 2024). Net income: US$660.0k (down 86% from 1Q 2024). Profit margin: 5.0% (down from 23% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Tillkännagivande • Oct 11
Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025 Aehr Test Systems, Inc. reaffirms earnings guidance for the fiscal year ending May 30, 2025. For the fiscal year ending May 30, 2025, Aehr is reiterating its previously provided guidance for total revenue of at least $70 million and net profit before taxes of at least 10% of revenue. Tillkännagivande • Oct 02
Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024 Aehr Test Systems, Inc. announced that they will report Q1, 2025 results After-Market on Oct 10, 2024 Tillkännagivande • Sep 12
Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024 Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024. Location: 400 kato terrace, california 94539, fremont United States Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €13.73, the stock trades at a trailing P/E ratio of 13.6x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 97% over the past three years. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €12.93, the stock trades at a trailing P/E ratio of 13.4x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 165% over the past three years. Recent Insider Transactions • Aug 01
Independent Director recently sold €172k worth of stock On the 30th of July, Fariba Danesh sold around 10k shares on-market at roughly €17.21 per share. This transaction amounted to 70% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €887k more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improves as stock rises 39% After last week's 39% share price gain to €13.92, the stock trades at a trailing P/E ratio of 28.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 338% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.58 per share. Buy Or Sell Opportunity • Jul 09
Now 33% overvalued after recent price rise Over the last 90 days, the stock has risen 3.9% to €11.63. The fair value is estimated to be €8.72, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year. Tillkännagivande • Jul 04
Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024 Aehr Test Systems announced that they will report Q4, 2024 results After-Market on Jul 16, 2024 Buy Or Sell Opportunity • Jul 01
Now 20% overvalued Over the last 90 days, the stock has fallen 6.0% to €10.36. The fair value is estimated to be €8.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year. Buy Or Sell Opportunity • Jun 27
Now 21% overvalued Over the last 90 days, the stock has fallen 12% to €9.95. The fair value is estimated to be €8.25, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €9.45, the stock trades at a trailing P/E ratio of 19.7x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 318% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €8.31 per share. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to €11.55, the stock trades at a trailing P/E ratio of 25.1x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 439% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.77 per share. Board Change • Jun 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Fariba Danesh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Buy Or Sell Opportunity • Jun 01
Now 27% overvalued Over the last 90 days, the stock has fallen 30% to €10.50. The fair value is estimated to be €8.26, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year. Buy Or Sell Opportunity • May 11
Now 22% overvalued Over the last 90 days, the stock has fallen 33% to €10.46. The fair value is estimated to be €8.60, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 6.6% in a year. Earnings are forecast to decline by 22% in the next year. New Risk • Apr 12
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 14% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings are forecast to decline by an average of 14% per year for the foreseeable future. High level of non-cash earnings (34% accrual ratio). Minor Risks Shareholders have been diluted in the past year (4.2% increase in shares outstanding). Significant insider selling over the past 3 months (€140k sold). Buy Or Sell Opportunity • Apr 10
Now 25% overvalued Over the last 90 days, the stock has fallen 31% to €11.20. The fair value is estimated to be €8.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 48% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Apr 10
Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023) Third quarter 2024 results: US$0.051 loss per share (down from US$0.15 profit in 3Q 2023). Revenue: US$7.56m (down 56% from 3Q 2023). Net loss: US$1.47m (down 136% from profit in 3Q 2023). Revenue is expected to decline by 5.7% p.a. on average during the next 2 years, while revenues in the Semiconductor industry in Germany are expected to grow by 8.3%. Over the last 3 years on average, earnings per share has increased by 83% per year whereas the company’s share price has increased by 79% per year. Tillkännagivande • Apr 10
Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024 Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share. Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €11.33, the stock trades at a trailing P/E ratio of 17x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 434% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.68 per share. Tillkännagivande • Mar 26
Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024 Aehr Test Systems announced that they will report Q3, 2024 results on Apr 09, 2024 Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €13.03, the stock trades at a trailing P/E ratio of 19.5x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 515% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.71 per share. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €15.96, the stock trades at a trailing P/E ratio of 23.1x. Average forward P/E is 19x in the Semiconductor industry in Germany. Total returns to shareholders of 571% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.08 per share. New Risk • Jan 22
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €147k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (52% accrual ratio). Minor Risks Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Significant insider selling over the past 3 months (€147k sold). Recent Insider Transactions • Jan 22
President recently sold €78k worth of stock On the 18th of January, Gayn Erickson sold around 5k shares on-market at roughly €16.01 per share. This transaction amounted to 1.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €5.7m. Reported Earnings • Jan 10
Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023) Second quarter 2024 results: EPS: US$0.21 (up from US$0.14 in 2Q 2023). Revenue: US$21.4m (up 45% from 2Q 2023). Net income: US$6.09m (up 64% from 2Q 2023). Profit margin: 28% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 214% p.a. on average during the next 2 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has increased by 122% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 10
Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024 Aehr Test Systems provided earnings guidance For the fiscal year ending May 31, 2024. For the year, the company is revising its expected full year total revenue to be between $75 million and $85 million, representing growth of 15% to 30% year over year, and GAAP net income of between 20% and 25% of revenue. Valuation Update With 7 Day Price Move • Nov 03
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €23.35, the stock trades at a trailing P/E ratio of 38.2x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,271% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.44 per share. Tillkännagivande • Oct 21
Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee Aehr Test Systems announced that Rhea J. Posedel resigned from the Corporate Governance and Nominating Committee of AEHR Test Systems Inc. (the “Company”) effective October 19, 2023. Although Mr. Posedel will continue to stand for election at the Company’s Annual Meeting of Shareholders (to be held on October 23, 2023, at 4:00 p.m.), he will not in the future be nominated or appointed to any of the Company’s committees made up of independent directors including the Corporate Governance and Nominating Committee, Audit Committee, and the Compensation Committee. The new chair of the Corporate Governance and Nominating Committee will be appointed at the upcoming meeting of the Board of Directors (the “Board”) on October 23, 2023. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €30.76, the stock trades at a trailing P/E ratio of 49x. Average forward P/E is 14x in the Semiconductor industry in Germany. Total returns to shareholders of 2,775% over the past three years. Reported Earnings • Oct 06
First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023) First quarter 2024 results: EPS: US$0.16 (up from US$0.022 in 1Q 2023). Revenue: US$20.6m (up 93% from 1Q 2023). Net income: US$4.67m (up US$4.09m from 1Q 2023). Profit margin: 23% (up from 5.5% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has increased by 236% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Oct 06
Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024 Aehr Test Systems reiterated earnings guidance for the fiscal year ending May 31, 2024. For the year, the company expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year. Tillkännagivande • Sep 27
Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023 Aehr Test Systems announced that they will report Q1, 2024 results at 5:00 PM, US Eastern Standard Time on Oct 05, 2023 Tillkännagivande • Sep 14
Aehr Test Systems, Annual General Meeting, Oct 23, 2023 Aehr Test Systems, Annual General Meeting, Oct 23, 2023, at 16:00 Pacific Daylight. Location: corporate headquarters located at 400 Kato Terrace Fremont California United States Agenda: to consider and elect six directors of the company to hold office until the next annual meeting or the election of their successors; to consider and ratify the selection of bpm llp as the company’s independent registered public accounting firm for the fiscal year ending may 31, 2024; to consider and approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof. Reported Earnings • Aug 30
Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022) Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 209% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to €37.53, the stock trades at a trailing P/E ratio of 77.7x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 2,260% over the past three years. Recent Insider Transactions • Jul 21
President recently sold €5.7m worth of stock On the 17th of July, Gayn Erickson sold around 124k shares on-market at roughly €45.65 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Gayn has been a net seller over the last 12 months, reducing personal holdings by €7.4m. Reported Earnings • Jul 14
Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022) Full year 2023 results: EPS: US$0.52 (up from US$0.36 in FY 2022). Revenue: US$65.0m (up 28% from FY 2022). Net income: US$14.6m (up 54% from FY 2022). Profit margin: 22% (up from 19% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has increased by 194% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jul 14
Aehr Test Systems Provides Earnings Guidance for the Year 2024 For the fiscal year ending May 31, 2024, Aehr Test Systems expects total revenue to be at least $100 million, representing growth of over 50% year over year, and GAAP net income of at least $28 million, representing earnings growth of greater than 90% year over year. Tillkännagivande • Jul 06
Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023 Aehr Test Systems announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Jul 13, 2023 Tillkännagivande • Jun 01
Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023 Aehr Test Systems announced the appointment of Chris Siu as the Company’s Chief Financial Officer, Executive Vice President of Finance, and Secretary effective June 1, 2023. He will succeed Ken Spink, who previously announced his planned retirement after 15 years with the Company. Mr. Spink will stay on through the completion of Aehr’s fiscal 2023 year that ends May 31, 2023 and annual 10-K filing to ensure an orderly transition. Mr. Siu brings more than 27 years of finance and accounting experience in the semiconductor, medical equipment, and public accounting industries. Before joining Aehr Test Systems, he most recently served four years in senior finance executive positions at publicly traded Ultra Clean Technologies, a global leading developer and supplier of critical subsystems, components and parts, and ultra-high purity clean and analytical services primarily for the semiconductor and semiconductor equipment industry, including Senior Vice President of Finance, Corporate Treasurer, and Chief Accounting Officer. Prior to Ultra Clean Technologies, Mr. Siu held senior management roles at PDF Solutions and also GlobalFoundries, a multinational semiconductor manufacturing company, where he served for eight years including leading all global accounting functions as Corporate Controller for four years. He was also Chief Accounting Officer and Director of Finance at semiconductor company Trident Microsystems and served in several senior finance management positions at medical device and software manufacturer Varian Medical Systems. Mr. Siu also worked three years with Deloitte and left as an Audit Manager, and began his career in public accounting serving over five years with EY. He is a Certified Public Accountant (inactive) in California. Mr. Siu holds a Bachelor of Science degree in Accounting from Brigham Young University in Hawaii and a Master of Business Administration degree from the University of California at Berkeley. Valuation Update With 7 Day Price Move • May 10
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €26.33, the stock trades at a trailing P/E ratio of 56x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,754% over the past three years. Valuation Update With 7 Day Price Move • Apr 25
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €21.40, the stock trades at a trailing P/E ratio of 48x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,229% over the past three years. Recent Insider Transactions • Apr 11
Independent Director recently sold €775k worth of stock On the 6th of April, Geoffrey Scott sold around 30k shares on-market at roughly €25.83 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €3.3m. Insiders have been net sellers, collectively disposing of €17m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment deteriorates as stock falls 26% After last week's 26% share price decline to €26.43, the stock trades at a trailing P/E ratio of 53.7x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,998% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €10.91 per share. Reported Earnings • Mar 31
Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022) Third quarter 2023 results: EPS: US$0.15 (up from US$0.083 in 3Q 2022). Revenue: US$17.2m (up 13% from 3Q 2022). Net income: US$4.13m (up 84% from 3Q 2022). Profit margin: 24% (up from 15% in 3Q 2022). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 8.9% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has increased by 192% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 09
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to €29.72, the stock trades at a trailing P/E ratio of 75.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,993% over the past three years. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to €34.54, the stock trades at a trailing P/E ratio of 78.1x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,576% over the past three years. Recent Insider Transactions • Feb 02
Insider recently sold €1.2m worth of stock On the 27th of January, Vernon Rogers sold around 38k shares on-market at roughly €32.60 per share. This transaction amounted to 50% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €7.8m more than they bought in the last 12 months. Tillkännagivande • Jan 28
Aehr Test Systems Announces Board Changes On January 24, 2023, Mario Rosati retired as a director of Aehr Test Systems. Mr. Rosati's action was voluntary and did not result from any disagreement with the Company or the Company's Board of Directors (the Board").On January 25, 2023 the Board appointed existing director Rhea Posedel to the Corporate Governance andNominating Committee, replacing Mr. Rosati in this position. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to €32.03, the stock trades at a trailing P/E ratio of 79.4x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 1,595% over the past three years. Recent Insider Transactions • Jan 13
Independent Director recently sold €381k worth of stock On the 10th of January, Geoffrey Scott sold around 15k shares on-market at roughly €25.41 per share. This transaction amounted to 4.6% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.7m. Insiders have been net sellers, collectively disposing of €4.3m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improved over the past week After last week's 60% share price gain to €25.95, the stock trades at a trailing P/E ratio of 62.9x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,492% over the past three years. Tillkännagivande • Jan 06
Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023 Aehr Test Systems reiterated revenue guidance for the fiscal year ending May 31, 2023. For the fiscal year ending May 31, 2023, Aehr is reiterating its previously provided guidance for total revenue to be $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also continues to expect bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade. Reported Earnings • Jan 06
Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022) Second quarter 2023 results: EPS: US$0.14 (up from US$0.027 in 2Q 2022). Revenue: US$14.8m (up 54% from 2Q 2022). Net income: US$3.73m (up 420% from 2Q 2022). Profit margin: 25% (up from 7.5% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 106% per year whereas the company’s share price has increased by 105% per year. Tillkännagivande • Dec 23
Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023 Aehr Test Systems announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Jan 05, 2023 Recent Insider Transactions • Nov 18
President recently sold €1.7m worth of stock On the 15th of November, Gayn Erickson sold around 70k shares on-market at roughly €24.93 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Gayn's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment improved over the past week After last week's 23% share price gain to €23.61, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 15x in the Semiconductor industry in Germany. Total returns to shareholders of 1,105% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €13.95 per share. Recent Insider Transactions • Nov 02
Vice President of Engineering recently sold €463k worth of stock On the 28th of October, Donald Richmond sold around 22k shares on-market at roughly €21.12 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €5.2m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 25% share price gain to €18.30, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 1,073% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €15.38 per share. Reported Earnings • Oct 08
First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022) First quarter 2023 results: EPS: US$0.022 (down from US$0.029 in 1Q 2022). Revenue: US$10.7m (up 89% from 1Q 2022). Net income: US$589.0k (down 15% from 1Q 2022). Profit margin: 5.5% (down from 12% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 35% p.a. on average during the next 2 years, compared to a 8.6% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has increased by 124% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €13.46, the stock trades at a trailing P/E ratio of 39.6x. Average forward P/E is 12x in the Semiconductor industry in Germany. Total returns to shareholders of 768% over the past three years. Tillkännagivande • Sep 24
Aehr Test Systems, Annual General Meeting, Oct 18, 2022 Aehr Test Systems, Annual General Meeting, Oct 18, 2022, at 16:00 Pacific Daylight. Location: 400 Kato Terrace, Fremont, California 94539 california United States Agenda: To elect seven directors of the company to hold office until the next annual meeting or the election of their successors; to approve an amendment to the company's amended and restated 2006 employee stock purchase plan (the "espp") to increase the number of shares reserved for issuance thereunder by an additional 350,000 shares of common stock of the company ("common stock"); to ratify the selection of BPM LLP as the company’s independent registered public accounting firm for the fiscal year ending May 31, 2023; to approve, on an advisory (non-binding) basis, the compensation of the company’s named executive officers; and to transact such other business as may properly come before the annual meeting or any postponements or adjournments thereof. Tillkännagivande • Sep 21
Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022 Aehr Test Systems announced that they will report Q1, 2023 results After-Market on Oct 06, 2022 Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment deteriorated over the past week After last week's 25% share price decline to €13.39, the stock trades at a trailing P/E ratio of 39.1x. Average forward P/E is 13x in the Semiconductor industry in Germany. Total returns to shareholders of 981% over the past three years. Reported Earnings • Aug 28
Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021) Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 12% growth forecast for the Semiconductor industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 148% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 09
Investor sentiment improved over the past week After last week's 27% share price gain to €15.04, the stock trades at a trailing P/E ratio of 42.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 1,200% over the past three years. Recent Insider Transactions • Aug 05
Independent Director recently sold €123k worth of stock On the 2nd of August, Howard Slayen sold around 10k shares on-market at roughly €12.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €13m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improved over the past week After last week's 21% share price gain to €10.45, the stock trades at a trailing P/E ratio of 30.7x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 741% over the past three years. Reported Earnings • Jul 21
Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021) Full year 2022 results: EPS: US$0.36 (up from US$0.086 loss in FY 2021). Revenue: US$50.8m (up 206% from FY 2021). Net income: US$9.45m (up US$11.5m from FY 2021). Profit margin: 19% (up from net loss in FY 2021). Over the next year, revenue is forecast to grow 22%, compared to a 14% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jul 20
Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023 Aehr Test Systems provided earnings guidance for the fiscal year 2023. For the year, the company expected total revenue to be at least $60 million to $70 million, with strong profit margins similar to last fiscal year. Aehr also expects bookings to grow faster than revenues in fiscal 2023 as the ramp in demand for silicon carbide in electric vehicles increases exponentially throughout the decade. Tillkännagivande • Jul 13
Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022 Aehr Test Systems announced that they will report fiscal year 2022 results at 4:00 PM, US Eastern Standard Time on Jul 19, 2022 Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improved over the past week After last week's 23% share price gain to €8.75, the stock trades at a trailing P/E ratio of 60.9x. Average forward P/E is 17x in the Semiconductor industry in Germany. Total returns to shareholders of 509% over the past three years. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 15% share price gain to €7.87, the stock trades at a trailing P/E ratio of 53.6x. Average forward P/E is 16x in the Semiconductor industry in Germany. Total returns to shareholders of 470% over the past three years. Tillkännagivande • Apr 03
Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022 Aehr Test Systems appointed Adil Engineer as the Company's Chief Operating Officer, effective April 6, 2022. David Fucci, Interim Vice-President of Operations with the Company, will remain through the fiscal year end May 31, 2022 to assist in the transition. Mr. Engineer, age 45, has built a career in operations and supply chain and has been in the semiconductor and medical equipment field for over 20 years. He started his career with semiconductor equipment company KLA-Tencor where he spent 11 years, and also worked at Coherent and Kateeva in positions of increasing responsibility in manufacturing, manufacturing engineering, new product introduction, and supply chain. Most recently he was the Head of Operations at Tecan, a Swiss company manufacturing medical test and diagnostic tools, devices, and solutions, where he oversaw operations for Tecan’s primary site in the US for manufacturing, located in San Jose. Adil has a Bachelor of Science in Chemical Engineering from TKIET, Shivaji University, India, and a Graduate Certificate in Management Science and Engineering from Leland Stanford Jr. University, Stanford, California. Mr. Engineer does not have a family relationship with any member of the Board or any executive officer of the Company, and Mr. Engineer has not been a participant or had an interest in any transaction with the Company that is reportable under Item 404(a) of Regulation S-K. Reported Earnings • Apr 02
Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021) Third quarter 2022 results: EPS: US$0.083 (up from US$0.031 loss in 3Q 2021). Revenue: US$15.3m (up 190% from 3Q 2021). Net income: US$2.24m (up US$2.98m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). Over the next year, revenue is forecast to grow 72%, compared to a 16% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.